Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Analysis of the Potential of Platelet Indices as a Predictor of Hematological Comorbidity in Patients with Diabetes Mellitus

Public Health of Indonesia · Vol. 11 No. 4 (2025) · hlm. 169–175

DOI
10.36685/phi.v11i4.1591
ISSN
2477-1570, 2528-1542
Terbit
2025-12-17
Penerbit
YCAB Publisher
Bahasa
eng
Lisensi
creativecommons.org/licenses/by-nc/4.0

Abstrak

Background: Diabetes Mellitus (DM) is one of the chronic diseases that is a global burden. The increase in DM cases poses a risk of complex comorbidities such as cardiovascular disease, kidney disease and hematological disorders. The Platelet indices (MPV, PDW, PCT, P-LCR) reflects platelet activation and has the potential to be a biomarker for predicting comorbidities, so it can help improve the quality of clinical management in DM patients. Objective: This study aims to evaluate the predictive potential of platelet indices as a biomarker of comorbidity hematology in DM patients. Methods: An analytical study with a cross-sectional design was conducted from June to July 2025 at the Bahteramas Regional Hospital, Indonesia, involving 100 patients with diabetes mellitus and 100 healthy individuals as controls selected through purposive sampling. Venous blood samples were taken from all participants to measure platelet indices (PLT, MPV, PDW, P-LCR) using an automated hematology analysis tool. Data analysis was carried out by an independent sample t-test to compare index values between groups, as well as an ROC curve to evaluate its predictive value against DM status, Statistical significance was set at p < 0.05. Results: showed that the mean platelet indices in the group of healthy individuals with PLT was 229.98 ×10³/μL and in DM patients with a mean value of 260.71 ×10³/μL, MPV in healthy individuals with MPV was obtained at 10.24 fL. In DM it rises to 10.46 fL. The PDW value in healthy individuals was 9.82 fL. In DM the average value increased to 11.80 fL, in Healthy Individuals PCT averaged 24.7%, In DM the value increased to 28.7%. The P-LCR value in healthy individuals was 22.12%. In DM, the average value increased to 25.80%, with a significant value of P< 0.05 which shows that between healthy patients and DM patients there is a significant difference in terms of PLT, MPV, PDW, PCT and P-LCR parameters. The ROC curve of each platelet parameter (PLT, MPV, PDW, PCT, and P-LCR) illustrates the sensitivity and specificity of the model in predicting the occurrence of comorbidities. This can be obtained from the Under the Curve Area Value (AUC) which shows that PDW has the highest AUC of 83.4%, which indicates the ability of the most effective parameters in predicting comorbidities in DM patients. Conclusions: This study shows that platelet indices, especially PDW values, has the most effective potential as a practical and easily accessible hematological biomarker for predicting comorbidity risk in patients with diabetes mellitus. These results confirm the role of the predictive value of platelet indices in early detection and risk stratification, which can support more proactive clinical decision-making and management of DM patients.

Kata kunci

Jaringan kolaborasi para penulis

11 penulis · 19 tautan kepenulisan bersama · 4 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Halu Oleo
  • Politeknik Bina Husada Kendari
  • Hasanuddin University
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
ABDUL RAHMANUniversitas Halu Oleo1
Abdul M. BalubiAfiliasi tidak diketahui1
Zulfiah LarisuUniversitas Halu Oleo1
Sartiah YusranUniversitas Halu Oleo1
Rustam RustamHasanuddin University1
Wawan GunawanAfiliasi tidak diketahui1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) http://stikbar.org/ycabpublisher/index.php/PHI/oai, pertama di-harvest 10 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Analysis of the Potential of Platelet Indices as a Predictor of Hematological Comorbidity in Patients with Diabetes Mellitus</dc:title>
	<dc:creator>Umar, Ani</dc:creator>
	<dc:creator>Wenty, Darmayanita </dc:creator>
	<dc:creator>Firdayanti</dc:creator>
	<dc:creator>Susanti</dc:creator>
	<dc:creator>Umar, Heni </dc:creator>
	<dc:subject xml:lang="en-US">platelet index</dc:subject>
	<dc:subject xml:lang="en-US">Diabates Mellitus</dc:subject>
	<dc:subject xml:lang="en-US">comorbidities</dc:subject>
	<dc:subject xml:lang="en-US">Hematology</dc:subject>
	<dc:subject xml:lang="en-US">Biomarker</dc:subject>
	<dc:description xml:lang="en-US">Background: Diabetes Mellitus (DM) is one of the chronic diseases that is a global burden. The increase in DM cases poses a risk of complex comorbidities such as cardiovascular disease, kidney disease and hematological disorders. The Platelet indices (MPV, PDW, PCT, P-LCR) reflects platelet activation and has the potential to be a biomarker for predicting comorbidities, so it can help improve the quality of clinical management in DM patients.
Objective: This study aims to evaluate the predictive potential of platelet indices as a biomarker of comorbidity hematology in DM patients.
Methods: An analytical study with a cross-sectional design was conducted from June to July 2025 at the Bahteramas Regional Hospital, Indonesia, involving 100 patients with diabetes mellitus and 100 healthy individuals as controls selected through purposive sampling. Venous blood samples were taken from all participants to measure platelet indices (PLT, MPV, PDW, P-LCR) using an automated hematology analysis tool. Data analysis was carried out by an independent sample t-test to compare index values between groups, as well as an ROC curve to evaluate its predictive value against DM status, Statistical significance was set at p &amp;lt; 0.05.
Results: showed that the mean platelet indices in the group of healthy individuals with PLT was 229.98 ×10³/μL and in DM patients with a mean value of 260.71 ×10³/μL, MPV in healthy individuals with MPV was obtained at 10.24 fL. In DM it rises to 10.46 fL. The PDW value in healthy individuals was 9.82 fL. In DM the average value increased to 11.80 fL, in Healthy Individuals PCT averaged 24.7%, In DM the value increased to 28.7%. The P-LCR value in healthy individuals was 22.12%. In DM, the average value increased to 25.80%, with a significant value of P&amp;lt; 0.05 which shows that between healthy patients and DM patients there is a significant difference in terms of PLT, MPV, PDW, PCT and P-LCR parameters. The ROC curve of each platelet parameter (PLT, MPV, PDW, PCT, and P-LCR) illustrates the sensitivity and specificity of the model in predicting the occurrence of comorbidities. This can be obtained from the Under the Curve Area Value (AUC) which shows that PDW has the highest AUC of 83.4%, which indicates the ability of the most effective parameters in predicting comorbidities in DM patients.
Conclusions: This study shows that platelet indices, especially PDW values, has the most effective potential as a practical and easily accessible hematological biomarker for predicting comorbidity risk in patients with diabetes mellitus. These results confirm the role of the predictive value of platelet indices in early detection and risk stratification, which can support more proactive clinical decision-making and management of DM patients.</dc:description>
	<dc:publisher xml:lang="en-US">YCAB Publisher</dc:publisher>
	<dc:date>2025-12-17</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://stikbar.org/ycabpublisher/index.php/PHI/article/view/1591</dc:identifier>
	<dc:identifier>10.36685/phi.v11i4.1591</dc:identifier>
	<dc:source xml:lang="en-US">Public Health of Indonesia; Vol. 11 No. 4 (2025): October - December; 169 - 175</dc:source>
	<dc:source>2477-1570</dc:source>
	<dc:source>2528-1542</dc:source>
	<dc:source>10.36685/phi.v11i4</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://stikbar.org/ycabpublisher/index.php/PHI/article/view/1591/638</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2025 Ani Ani Umar</dc:rights>
	<dc:rights xml:lang="en-US">https://creativecommons.org/licenses/by-nc/4.0</dc:rights>
</oai_dc:dc>